Aggressive versus Low Dose Inhibition of the Renin-Angiotensin System for the Treatment of Microalbuminuria in Type 2 Diabetic Patients: A Pilot Study
ISRN Endocrinology · 2011
DOI: 10.5402/2011/696124 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN Endocrinology, 2011. Verfasst von M B Davidson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Charles R. Drew University, Los Angeles, CA 90059, USA. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Objective
This study compares low dose versus aggressive inhibition of the renin angiotensin system (RAS) to treat microalbuminuria (MA).
Methods
Patients with MA after a run-in period to control BP to
Autor:innen und Institutionen
- Department of Internal Medicine, Charles R. Drew University, Los Angeles, CA 90059, USA.
Förderung
- National Institutes of Health
Zitieren
APA
Davidson, M. B., Tareen, N., Duran, P., Aguilar, V., & Lee, M. L. (2011). Aggressive versus Low Dose Inhibition of the Renin-Angiotensin System for the Treatment of Microalbuminuria in Type 2 Diabetic Patients: A Pilot Study. ISRN Endocrinology. https://doi.org/10.5402/2011/696124
Vancouver
Davidson MB, Tareen N, Duran P, Aguilar V, Lee ML. Aggressive versus Low Dose Inhibition of the Renin-Angiotensin System for the Treatment of Microalbuminuria in Type 2 Diabetic Patients: A Pilot Study. ISRN Endocrinology. 2011. doi:10.5402/2011/696124
BibTeX
@article{Davidson2011,
author = {Davidson, M B and Tareen, N and Duran, P and Aguilar, V and Lee, M L},
title = {Aggressive versus Low Dose Inhibition of the Renin-Angiotensin System for the Treatment of Microalbuminuria in Type 2 Diabetic Patients: A Pilot Study},
journal = {ISRN Endocrinology},
year = {2011},
doi = {10.5402/2011/696124}
}
EUVIMED